Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mara Renewables is a leading Canadian biotechnology company specializing in the sustainable production of high-value nutritional ingredients from microalgae. Utilizing a proprietary heterotrophic fermentation platform, the company produces docosahexaenoic acid (DHA), a critical Omega-3 fatty acid, as a vegan and environmentally friendly alternative to traditional fish oil. Its products are primarily supplied to the global infant formula, dietary supplement, and functional food and beverage industries. Headquartered in Nova Scotia, Mara maintains a significant intellectual property portfolio and operates at a commercial scale to meet the rising global demand for plant-based nutritional solutions. The company is recognized for its commitment to reducing the environmental impact of essential nutrient production while maintaining high quality and purity standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mara Renewables.